4540 Stock Overview
Tsumura & Co. manufactures and sells pharmaceutical products worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 3/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 4/6 |
Tsumura & Co. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥3,759.00 |
| 52 Week High | JP¥4,082.00 |
| 52 Week Low | JP¥2,551.00 |
| Beta | 0.19 |
| 1 Month Change | -3.39% |
| 3 Month Change | 40.08% |
| 1 Year Change | 38.20% |
| 3 Year Change | 2.99% |
| 5 Year Change | 10.07% |
| Change since IPO | 140.96% |
Recent News & Updates
News Flash: Analysts Just Made A Sizeable Upgrade To Their Tsumura & Co. (TSE:4540) Forecasts
Mar 28
Tsumura (TSE:4540) Will Pay A Dividend Of ¥35.00
Mar 15Earnings Not Telling The Story For Tsumura & Co. (TSE:4540) After Shares Rise 39%
Mar 07Recent updates
Shareholder Returns
| 4540 | JP Pharmaceuticals | JP Market | |
|---|---|---|---|
| 7D | -3.1% | 1.1% | -1.0% |
| 1Y | 38.2% | 3.7% | 27.9% |
Return vs Industry: 4540 exceeded the JP Pharmaceuticals industry which returned 3.7% over the past year.
Return vs Market: 4540 exceeded the JP Market which returned 27.9% over the past year.
Price Volatility
| 4540 volatility | |
|---|---|
| 4540 Average Weekly Movement | 7.8% |
| Pharmaceuticals Industry Average Movement | 3.7% |
| Market Average Movement | 4.1% |
| 10% most volatile stocks in JP Market | 8.1% |
| 10% least volatile stocks in JP Market | 2.2% |
Stable Share Price: 4540's share price has been volatile over the past 3 months.
Volatility Over Time: 4540's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of JP stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1893 | 4,032 | Terukazu Kato | www.tsumura.co.jp |
Tsumura & Co. manufactures and sells pharmaceutical products worldwide. The company offers Kampo extract intermediates and granular Kampo formulations. It is involved in the procurement, selection and processing, and storage of raw material crude drugs and crude drug pieces for decoction; manufacture of Kampo powdered extracts and traditional Chinese medicines; and sale of pharmaceuticals and food products.
Tsumura & Co. Fundamentals Summary
| 4540 fundamental statistics | |
|---|---|
| Market cap | JP¥285.41b |
| Earnings (TTM) | JP¥16.76b |
| Revenue (TTM) | JP¥148.79b |
17.0x
P/E Ratio1.9x
P/S RatioIs 4540 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4540 income statement (TTM) | |
|---|---|
| Revenue | JP¥148.79b |
| Cost of Revenue | JP¥78.01b |
| Gross Profit | JP¥70.78b |
| Other Expenses | JP¥54.02b |
| Earnings | JP¥16.76b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 09, 2024
| Earnings per share (EPS) | 220.71 |
| Gross Margin | 47.57% |
| Net Profit Margin | 11.26% |
| Debt/Equity Ratio | 26.8% |
How did 4540 perform over the long term?
See historical performance and comparison